UNSPSC 51294516: Altanserin tartrate

This classification denotes a serotonin antagonist with the molecular formula C22H22FN3O2S.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9P204CHE8J, chemically known as 4(1h)-quinazolinone, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-2,3-dihydro-2-thioxo-, (r-(r*,r*))-2,3-dihydroxybutanedioate but more generally known as altanserin tartrate, which bears US NIH Compound Identifier 3033676. Most nations, for tariff and trade purposes, schedule altanserin tartrate under HS 29335995 and SITC 51576.

As of Q4 2014, ALTANSERIN TARTRATE remains US FDA's Preferred Term for this commodity. Altanserin tartrate bears US NLM identifiers UMLS ID C2698070 and NCI Concept Code C79965. SMILES: C1CCC2C(C1)C(=O)N(C(=S)[NH]2)CCN3CCC(CC3)C(=O)C4CCC(CC4)F.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51294516 Altanserin tartrate, a Commodity code, shows minimal alignment with recent state and local procurement activity. The code nominally classifies a specific pharmaceutical compound, yet the single recent opportunity posted under it — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and drug deactivation systems for community health initiatives, a scope that does not match the code's pharmaceutical classification. Naloxone is an opioid antagonist used for overdose reversal, while altanserin tartrate is a selective serotonin 5-HT2A receptor antagonist with different clinical applications; the mismatch suggests either a tagging error by the issuing jurisdiction or a data artifact rather than genuine procurement activity under this code's intended scope.

Seminole County, Florida released the naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2023 (note the date discrepancy in the source record), seeking 1,900 units of naloxone and 800 deactivation systems annually on a two-year term with a one-year renewal option. Quarterly deliveries are required to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs. The procurement carries standard state and local compliance requirements including drug-free workplace certification, E-Verify verification, workers' compensation and commercial general liability insurance, and possible FEMA funding with associated federal environmental compliance obligations. No recent opportunities for altanserin tartrate itself appear in the available records, and the code warrants low priority pending clarification of whether it reflects genuine pharmaceutical procurement or a classification error.